Home Therapy with Subcutaneous Anti-Immunoglobulin-E Antibody Omalizumab in 25 Patients with Immunoglobulin-E-Mediated (Allergic) Asthma

By Liebhaber Myron   Dyer Zeb  

Journal of Asthma, Vol. 44, Iss. 3, 2007-04 ,pp. : 195-196

Informa Healthcare

Access to resources Recommend Favorite

Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma

By Özgür Eylem Sercan   Özge Cengiz   Ïlvan Ahmet   Naycı Sibel Atış  

Journal of Asthma, Vol. 50, Iss. 6, 2013-08 ,pp. : 687-694

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study

By Barnes Neil  

Journal of Asthma, Vol. 50, Iss. 5, 2013-06 ,pp. : 529-536

Informa Healthcare

Access to resources Recommend Favorite

Omalizumab in Children with Severe Allergic Asthma: The Italian Real- Life Experience

By  

Current Respiratory Medicine Reviews, Vol. 13, Iss. 1, 2017-10 ,pp. : 36-42

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of Omalizumab in a Patient with Severe Asthma, Low Serum IgE Level, and Lack of Sensitized Allergens Induced by Oral Steroid Therapy: The Usefulness of Impulse Oscillation for Assessment of Omalizumab Therapy

By Matsuno Osamu   Komori Chika   Hang Yuki   Matsumoto Tomoshige   Minamoto Seijiro  

Journal of Asthma, Vol. 49, Iss. 8, 2012-10 ,pp. : 839-842

Informa Healthcare

Access to resources Recommend Favorite